2025年11月, 實地研究
Popular U.S. large‑cap core and growth indexes have become more top heavy and skewed toward high‑growth stocks. So have the passive strategies that track these benchmarks and the actively managed ones that aim to beat them.
This rising concentration has been a boon for U.S. equities over the past decade. Strong business fundamentals for the giants of the digital age and the companies supplying the artificial intelligence (AI) boom have driven robust market returns.
But can an investment portfolio contain too much of a good thing?
The 10 largest companies represented more than 38% of the S&P 500 Index at the end of the third quarter—an unprecedented level. We don’t know when this overexposure will shift from a tailwind to a headwind. However, history underscores the value that diversification can add when extremely crowded markets eventually disperse (Figures 1A and 1B).
A top‑heavy U.S. equity market and the drift toward an increasingly narrow approach to growth investing may not reflect the widening range of long‑term outcomes that typify major innovation waves, such as the rise of AI.
December 31, 1965, to September 30, 2025.
Past performance is not a guarantee or a reliable indicator of future results.
Source: T. Rowe Price calculations using data from FactSet Research Systems Inc. All.rights reserved.
The 10 largest weightings in the S&P 500 Index and the rest of the index are reconstituted monthly. Total returns are capitalization weighted.
The mega‑cap technology companies that have an outsized influence on the U.S. stock market’s fortunes appear well positioned to benefit from the AI revolution. These behemoths boast massive user bases, troves of valuable data, computing power, and abundant financial resources.
However, AI competition could create real challenges for some of the mega‑caps’ core business models, from online search and advertising to enterprise software and cloud computing. Worries about this risk—and the pursuit of potentially compelling growth opportunities—are fueling massive spending on AI infrastructure and capabilities.
The urgency and magnitude of these AI‑related investments could pressure some of the mega‑caps’ free cash flow (FCF) and profitability in the near term, particularly if sufficient returns on investment take time to materialize.
How the AI revolution will play out is uncertain. But for the first time in a long time, the heavyweights at the top of the index are showing signs of potential vulnerability.
Many early AI winners have been the companies providing critical components to the infrastructure boom that has emerged as a key growth engine for the otherwise lackluster U.S. economy.1 As value creation gradually shifts from AI enablers to AI adopters, the market leadership baton could change hands.
AI’s broad applicability also suggests that, over a longer time frame, the potential productivity and earnings benefits from this technology could accrue to a broader range of industries than during the buildout phase. In a data‑intensive industry like insurance, for example, game‑changing productivity benefits could reinforce the competitive advantages of scaled players that are leading the way on AI adoption.
Bottom line: A market environment where the biggest winners keep winning by such a large margin isn’t necessarily a given over the long run.
How can investors position a U.S. equity portfolio for a wider range of outcomes without diluting their growth exposure and giving up too much potential upside participation?
Consider the diversification benefits of a strategy that applies a different lens to growth investing.
Dividend growers2 can offer a combination of defense and offense that may be hard to come by in other strategies.
December 31, 1985, to December 31, 2024.
Past performance is not a guarantee or a reliable indicator of future results.
Sources: Compustat and FTSE/Russell. Analysis by T. Rowe Price.
1 The market environments reflect the Russell 1000 Index’s rolling 12-month returns, measured monthly. At the start of every month, T. Rowe Price sorts the Russell 1000 Index into various categories depending on dividend policy. We then calculate that month’s market cap-weighted returns for each category. We accumulate the returns during the full periods and calculate the annualized total returns for each category. Dividend growers consist of companies whose dividend growth over the prior 12 months was greater than zero. Non-dividend payers consist of companies whose current dividend yield equals zero.
December 31, 1995, to September 30, 2025.
Past performance is no guarantee or a reliable indicator of future results.
Index performance is for illustrative purposes only and is not indicative of any specific investment.
Investors cannot invest directly in an index.
Source: Standard & Poor’s. Analysis by T. Rowe Price.
This past resilience reflects the value of dividends in tough markets. Dividends paid to shareholders are the only portion of a stock’s return that is always positive, providing a bit of shock absorption when the market is flat or down.
The discipline involved in paying a regularly scheduled dividend—especially one that has risen steadily over time—means that these companies have characteristics that are appealing in any market environment.
These qualities and historical return profile suggest that a dividend growth strategy could be easier to hold through the market’s ups and downs. Timing may also be less of a concern versus other investment approaches.
Playing a different game can also allow for more balanced exposure to a greater variety of growth stories, even in a highly concentrated market. Focusing on stronger‑for‑longer dividend growth usually leads to quality companies that have the potential to increase their top and bottom lines consistently and exhibit less earnings variability across the economic cycle.
Such an approach, in other words, favors companies that can provide what resembles a regular paycheck which increases over time. Of course, no dividend payment is guaranteed. Selectivity and a deep understanding of individual companies are critical to identifying potential durable growers.
An investment strategy seeking consistent dividend growth also tends to limit exposure to lottery ticket‑like stocks associated with popular themes. These companies haven’t necessarily generated earnings but do generate a lot of speculation about their future growth prospects. Gains in these sentiment‑driven stocks can reverse quickly if the narrative shifts.
But a dividend growth strategy does not mean forgoing secular growth stories, even if many of the companies at the top of the market don’t prioritize more than a token payout.
A disciplined focus on dividend growers can lead to differentiated exposure to promising themes, which can be attractive at a time when so much of the market is piling into so many of the same popular stocks.
Dividend growers may lag during market rallies when investor sentiment and a stock’s momentum take precedence over fundamentals, such as valuation and business quality.
Sticking with a dividend growth strategy can provide useful diversification while creating an opportunity to compound returns over the long term.
1 See Tim Murray’s T. Rowe Price white paper, “Have U.S. Stocks Become Too Expensive?”
2 Dividends are not guaranteed and are subject to change.
3 See John Hall’s T. Rowe Price white paper, “Drugging the Undruggable: How Biotech Innovation is Creating Opportunity for Investors.”
Risks:
Growth stocks are subject to the volatility inherent in common stock investing, and their share price may fluctuate more than that of a income‑oriented stocks. Diversification cannot assure a profit or protect against loss in a declining market. Investing in technology stocks entails specific risks, including the potential for wide variations in performance and usually wide price swings, up and down. Technology companies can be affected by, among other things, intense competition, government regulation, earnings disappointments, dependency on patent protection and rapid obsolescence of products and services due to technological innovations or changing consumer preferences. Health sciences firms are often dependent on government funding and regulation and are vulnerable to product liability lawsuits and competition from low‑cost generic product. Active investing may have higher costs than passive investing and may underperform the broad market or passive peers with similar objectives. All charts and tables are shown for illustrative purposes only.
Additional Disclosure
Visit troweprice.com/glossary for definitions of financial terms.
Please see vendor indices disclaimers for more information about the sourcing information: www.troweprice.com/marketdata.
Important Information
Where securities are mentioned, the specific securities identified and described are for informational purposes only and do not represent recommendations.
This material is being furnished for general informational purposes only. The material does not constitute or undertake to give advice of any nature, including fiduciary investment advice. Prospective investors are recommended to seek independent legal, financial and tax advice before making any investment decision. T. Rowe Price group of companies including T. Rowe Price Associates, Inc. and/or its affiliates receive revenue from T. Rowe Price investment products and services. Past performance is not a guarantee or a reliable indicator of future results. Investment involves risks. The value of an investment and any income from it can go down as well as up. Investors may get back less than the amount invested.
The material does not constitute a distribution, an offer, an invitation, a personal or general recommendation or solicitation to sell or buy any securities in any jurisdiction or to conduct any particular investment activity. The material has not been reviewed by any regulatory authority in any jurisdiction.
Information and opinions presented have been obtained or derived from sources believed to be reliable and current; however, we cannot guarantee the sources’ accuracy or completeness. There is no guarantee that any forecasts made will come to pass. The views contained herein are as of the date written and are subject to change without notice; these views may differ from those of other T. Rowe Price group companies and/or associates. Under no circumstances should the material, in whole or in part, be copied or redistributed without consent from T. Rowe Price
The material is not intended for use by persons in jurisdictions which prohibit or restrict the distribution of the material and in certain countries the material is provided upon specific request.
Hong Kong—Issued by T. Rowe Price Hong Kong Limited, 6/F, Chater House, 8 Connaught Road Central, Hong Kong. T. Rowe Price Hong Kong Limited is licensed and regulated by the Securities & Futures Commission (“SFC”). This material has not been reviewed by the SFC.
Singapore—Issued by T. Rowe Price Singapore Private Ltd. (UEN 201021137E), 501 Orchard Road, #10-02 Wheelock Place, Singapore 238880. T. Rowe Price Singapore Private Ltd. is licensed and regulated by the Monetary Authority of Singapore. This advertisement or publication has not been reviewed by the Monetary Authority of Singapore.
© 2025 T. Rowe Price. All Rights Reserved. T. ROWE PRICE, INVEST WITH CONFIDENCE, the Bighorn Sheep design and related indicators (see troweprice.com/ip) are trademarks of T. Rowe Price Group, Inc. All other trademarks are the property of their respective owners.